Atlas Trials

Effectiveness and Safety of Topical Ranibizumab for Treatment of Corneal Neovascularization (NV)

Clinical trial NCT00681889 · COMPLETED

Trial details

NCT number
NCT00681889
Sponsor
Reza Dana, MD
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Corneal Neovascularization
Start date
2008-04-01
Primary completion
2009-09-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.